News
Safestore Holdings PLC - Hertfordshire, England-based self-storage provider with more than 200 stores in UK, France, Spain and Benelux - CEO Frederic Vecchioli buys 135,000 shares at GBP5.42 and ...
Dr. Z's legacy will be written into the pages of the Congressional Record, so history will never forget one of Baltimore's most compassionate citizens.
AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization to RINVOQ� (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA) in ...
NEW YORK, NY / ACCESS Newswire / April 7, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential ...
The pharma giant is wagering potentially billions of dollars on technology from ABL Bio that’s designed to get drugs across ...
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK ...
NEW YORK CITY, NY / ACCESS Newswire / April 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
GSK Plc and Pfizer Inc. settled a patent-infringement lawsuit over competing vaccines for RSV, ending the dispute in Delaware ...
The addition of subcutaneous daratumumab to triplet therapy improved outcomes for certain patients with newly diagnosed ...
GSK plans the therapy’s commercial launch in the US for the second half of 2025. Credit: MAXSHOT.PL/Shutterstock. The US Food and Drug Administration (FDA) has approved GSK’s triazaacenaphthylene ...
Compazine, first approved for use in 1956, is no longer sold under that brand name in the United States. Today, it is mostly sold as a generic drug or under other brand names such as Ametil, Buccastem ...
About half of all women will experience a UTI at some point in their lives, and about 30% will have a UTI that comes back after treatment, drugmaker GSK said. Recurrent UTIs have become a bigger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results